The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets

SL Wood, M Pernemalm, PA Crosbie… - Cancer treatment …, 2014 - Elsevier
Non-small cell lung cancer (NSCLC) accounts for> 80% of lung cancer cases and currently
has an overall five-year survival rate of only 15%. Patients presenting with advanced stage …

Noninvasive staging of non-small cell lung cancer: a review of the current evidence

EM Toloza, L Harpole, DC McCrory - Chest, 2003 - Elsevier
Study objectives To determine the test performance characteristics of CT scanning, positron
emission tomography (PET) scanning, MRI, and endoscopic ultrasound (EUS) for staging …

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice …

GA Silvestri, AV Gonzalez, MA Jantz, ML Margolis… - Chest, 2013 - Elsevier
Background Correctly staging lung cancer is important because the treatment options and
prognosis differ significantly by stage. Several noninvasive imaging studies and invasive …

Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines

GA Silvestri, MK Gould, ML Margolis, LT Tanoue… - Chest, 2007 - Elsevier
Background Correctly staging lung cancer is important because the treatment options and
the prognosis differ significantly by stage. Several noninvasive imaging studies including …

Distribution of distant metastases from newly diagnosed non-small cell lung cancer

LE Quint, S Tummala, LJ Brisson, IR Francis… - The Annals of thoracic …, 1996 - Elsevier
BACKGROUND.: The purpose of our study was to determine the incidence and locations of
M1 disease at presentation in patients with non-small cell lung cancer to help design …

The noninvasive staging of non-small cell lung cancer: the guidelines

GA Silvestri, LT Tanoue, ML Margolis, J Barker… - Chest, 2003 - Elsevier
Correctly staging lung cancer is extremely important because the treatment options and the
prognosis differ significantly by stage. Several noninvasive imaging studies are available to …

Staging non-small cell lung cancer with whole-body PET

EM Marom, HP McAdams, JJ Erasmus, PC Goodman… - Radiology, 1999 - pubs.rsna.org
PURPOSE: To compare the accuracies of whole-body 2-[fluorine 18] fluoro-2-deoxy-d-
glucose (FDG) positron emission tomography (PET) and conventional imaging (thoracic …

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

T Bury, A Barreto, F Daenen, N Barthelemy… - European journal of …, 1998 - Springer
Despite advances in morphological imaging, some patients with lung cancer are found to
have non resectable disease at surgery or die of recurrence within a year of surgery. At …

[图书][B] Computed body tomography with MRI correlation

EY Lee, A Hunsaker, B Siewert - 2019 - books.google.com
Authoritative, clinically oriented, and unique in the field, Computed Body Tomography with
MRI Correlation, 5th Editionis your one-stop reference for current information on CT and MRI …

Predicting pulmonary complications after pneumonectomy for lung cancer

FJ Algar, A Alvarez, A Salvatierra… - European journal of …, 2003 - academic.oup.com
Objectives: Patients undergoing pneumonectomy for lung cancer are thought to be at high
risk for the development of postoperative pulmonary complications (PC) and these …